LM Dember, V Sanchorawala, DC Seldin, DG … - Annals of internal medicine, 2001 - Am Coll Physicians Effect of Dose-Intensive Intravenous Melphalan and Autologous ... Blood
Stem-Cell Transplantation on AL Amyloidosis–Associated ... Laura M. Dember,
MD; Vaishali Sanchorawala, MD; David C. Seldin, MD, PhD; Daniel G. Wright, ... Cited by 68 - Related articles - BL Direct - All 5 versions
V Sanchorawala, DG Wright, DC Seldin, LM … - Bone Marrow Transplantation, 2001 - ncbi.nlm.nih.gov Primary or AL amyloidosis results from a plasma cell dyscrasia in which
fibrillar light chain protein deposition leads to organ failure and death.
Standard treatment for AL amyloidosis has been oral melphalan and ... Cited by 119 - Related articles - BL Direct - All 3 versions
P Moreau, V Leblond, P Bourquelot, T Facon, … - British journal of haematology, 1998 - interscience.wiley.com We retrospectively investigated the feasibility and the toxicity of autologous
stem cell transpantation (ASCT) in 21 cases of systemic amyloidosis (AL). The
conditioning regimens consisted of high-dose melphalan (HDM) alone (n = 18) ... Cited by 135 - Related articles - BL Direct - All 4 versions
M Skinner, JJ Anderson, R Simms, R Falk, M … - The American journal of medicine, 1996 - Elsevier Patients were randomized to MPC or C with stratification according to sex, time
from diagnosis to study entry (ie, less than 3 months or 3 to 12 months), and
dominant organ system involvement (ie, cardiac, renal, neurologic, or ... Cited by 213 - Related articles - BL Direct - All 8 versions
MA Gertz, MQ Lacy, A Dispenzieri, DA … - The American journal of medicine, 2002 - Elsevier Amyloid was seen clinically in the kidneys (n = 45 patients), heart (n = 32),
peripheral nerves (n = 11), and liver (n = 11). A monoclonal protein was found
in the serum in 46 patients and in the urine in 57 patients. The median ... Cited by 118 - Related articles - All 10 versions
MA Gertz, RA Kyle, WM O'Fallon - Archives of Internal Medicine, 1992 - archinte.highwire.org Page 1. Dialysis Support of Patients With Primary Systemic Amyloidosis A Study of
211 Patients Morie A. Gertz, MD; Robert A. Kyle, MD; W. Michael O'Fallon, PhD ... Cited by 56 - Related articles - BL Direct - All 4 versions
- ►bloodjournal.org RL Comenzo, E Vosburgh, RH Falk, V … - Blood, 1998 - Am Soc Hematology AL (amyloid light-chain) amyloidosis is an uncommon plasma cell disorder in
which depositions of amyloid light-chain protein cause progressive organ failure
and death in a median of 13 months. Autologous stem-cell transplantation is ... Cited by 197 - Related articles - BL Direct - All 9 versions
DC Seldin, JJ Anderson, V Sanchorawala, K … - Blood, 2004 - bloodjournal.hematologylibrary.org Treatment of AL amyloidosis patients with high-dose melphalan chemotherapy
followed by autologous peripheral blood stem cell transplantation (HDM/SCT) can
produce hematologic complete responses (CRs) and improvement in organ ... Cited by 50 - Related articles - BL Direct - All 14 versions
- ►hematologylibrary.org [PDF] RL Comenzo, E Vosburgh, RW Simms, P … - Blood, 1996 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 115 - Related articles - BL Direct - All 4 versions
